Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

SMS Lifesciences India Ltd

Pharmaceuticals & Biotechnology | Small Cap

SMS Lifesciences India Ltd Health Insights
Health Score : 6.59Health Score : 6.59

SMS Lifesciences India Ltd operates within the Healthcare Services industry. The company demonstrates strong solvency and growth, with excellent scores in these areas. Profitability and coverage ratios are also good, indicating a solid financial standing. However, liquidity and efficiency ratios suggest areas needing attention. The company shows robust growth across revenue, operating profit, EPS, assets and net income. While the company maintains a good balance between debt and equity, its ability to meet short-term obligations and efficiently manage assets could be improved. Overall, SMS Lifesciences exhibits a mixed financial profile, characterized by high growth and profitability but constrained by liquidity and efficiency challenges.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
SMS Lifesciences India Ltd Health Insights
Health Score : 6.59Health Score : 6.59

SMS Lifesciences India Ltd operates within the Healthcare Services industry. The company demonstrates strong solvency and growth, with excellent scores in these areas. Profitability and coverage ratios are also good, indicating a solid financial standing. However, liquidity and efficiency ratios suggest areas needing attention. The company shows robust growth across revenue, operating profit, EPS, assets and net income. While the company maintains a good balance between debt and equity, its ability to meet short-term obligations and efficiently manage assets could be improved. Overall, SMS Lifesciences exhibits a mixed financial profile, characterized by high growth and profitability but constrained by liquidity and efficiency challenges.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Undervalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Undervalued

P/E RATIO (TTM)

22.80

Undervalued

Industry Median

28.62

Undervalued
Neutral

Small Cap Median

27.17

Neutral

P/E RATIO

21.20

P/B RATIO

2.06

Undervalued

Industry Median

3.17

Undervalued
Undervalued

Small Cap Median

2.62

Undervalued

P/S RATIO

1.23

Highly Undervalued

Industry Median

3.42

Highly Undervalued
Undervalued

Small Cap Median

2.55

Undervalued

Others

Neutral

PEG RATIO

1.45

Neutral
Neutral

EV/EBITDA RATIO

8.46

Neutral

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1410.2 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The growth ratios display a strong upward trend, showing SMS Lifesciences is significantly expanding. High growth in revenue, operating profit, EPS, assets, and net income indicates robust business performance. This growth reflects effective strategies and market positioning. The company is experiencing substantial expansion across various financial metrics. The weighted average calculation underscores the consistent and strong growth trajectory.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue Growth Rate1.9231.58-9.71-3.1612.75
Operating Profit Growth Rate2016.67-17.146.945.16
Earnings Per Share (EPS) Growth33.286.73-54.73-20.68121.22
Asset Growth RateN/A18.2110.64-1.01-0.26
Net Income Growth Rate4078.57-56-45.45216.67
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 3.80

The financial ratios is mixed, showing inconsistent performance across key metrics. While the book value per share is average, adjusted EPS, cash EPS, and dividend per share are relatively low. Capital expenditures are a concern, suggesting potential underinvestment. These factors collectively impact the company's overall financial health and long-term sustainability. It might face challenges in securing funding for future projects. The weighted average calculation highlights the mixed performance across these financial metrics.

WeakAdjusted Earnings Per Share (Adjusted EPS)Weak
WeakCash Earnings Per Share (Cash EPS)Weak
AverageBook Value Per ShareAverage
WeakDividend Per Share (DPS)Weak
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Adjusted Earnings Per Share (Adjusted EPS)46.6783.3336.672063.33
Cash Earnings Per Share (Cash EPS)73.33116.6773.3370113.33
Book Value Per Share430506.67563.33590656.67
Dividend Per Share (DPS)1.351.681.521.51.33
Capital Expenditures (CapEx)35.541.542.820.815
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 9.80

The profitability ratios demonstrate a strong ability to generate profits. High gross profit margin, ROCE, ROE, ROA, operating margin, and net margin indicate efficient operations and effective management. This profitability reflects the company's ability to control costs and maximize revenue. This ensures long-term sustainability and shareholder value. The weighted average calculation highlights the consistent strength in profitability metrics.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
GoodReturn on Assets (ROA)Good
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Gross Profit Margin8.277.145.75.238.7
Return on Capital Employed (ROCE)10.7314.237.366.3711.55
Return on Equity (ROE)10.8516.436.461.828.94
Return on Assets (ROA)9.939.87.347.9311.54
Operating Margin11.28109.1810.1313.04
Net Margin5.267.143.481.965.51
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.33

The efficiency ratios indicate mixed performance in asset utilization. While the receivables turnover is average, the fixed asset and capital turnover ratios suggest underutilization of assets. High days sales in inventory and receivable days indicate potential inefficiencies in inventory and credit management. These factors may impact the company's ability to generate revenue from its asset base. It also means money is tight because sales are taking more time. The weighted average calculation highlights the recent challenges in optimizing asset utilization.

PoorFixed Asset Turnover RatioPoor
WeakInventory Turnover RatioWeak
AverageReceivables Turnover RatioAverage
PoorDays Sales in Inventory RatioPoor
WeakReceivable DaysWeak
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Fixed Asset Turnover Ratio2.052.461.391.371.49
Inventory Turnover Ratio7.844.443.493.474.26
Receivables Turnover Ratio15.6510.297.96.315.75
Days Sales in Inventory Ratio46.5682.21104.58105.1985.68
Receivable Days23.3235.4746.257.8463.48
Capital Turnover Ratio1.141.280.970.971.14
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 8.80

The coverage ratios is strong, indicating a good ability to meet its interest and dividend obligations. The interest coverage ratio suggests the company can comfortably pay its interest expenses from its earnings. High dividend coverage indicates a high capacity to cover dividend payments. This showcases financial stability and security for investors. The weighted average calculation highlights the consistent strength in meeting coverage obligations.

GoodInterest Coverage RatioGood
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Interest Coverage Ratio456.53.4323.89
Equity Dividend Coverage RatioN/A33.3350252050
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The solvency ratios reflect a strong position, indicating a healthy balance between debt and equity. The low debt ratio and debt-to-equity ratio suggest that the company relies more on equity than debt to finance its assets. The high equity ratio further confirms the financial stability and lower risk of financial distress. The improving debt to asset ratio demonstrates controlled use of debt. This indicates long-term financial stability and resilience. The weighted average calculation underscores the continued strength in solvency management.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debt Ratio0.230.220.250.170.09
Debt to Equity Ratio0.30.280.330.20.1
Equity Ratio0.770.780.750.830.91
Debt To Asset Ratio0.130.120.140.090.05
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 3.08

The liquidity position reflects challenges in meeting short-term obligations. The current and cash ratios indicate limited ability to cover immediate liabilities with current assets and cash. The quick ratio offers a slightly better, but still weak, view when excluding inventory. The operating cash flow ratio, while slightly better, could be improved to enhance the company's short-term financial health. These ratios collectively suggest potential difficulties in managing working capital effectively. The weighted average calculation places emphasis on recent performance, highlighting the need for improvement in liquidity management.

PoorCurrent RatioPoor
WeakQuick RatioWeak
PoorCash RatioPoor
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Current Ratio1.011.010.980.910.91
Quick Ratio0.540.490.470.450.53
Cash Ratio0.080.020.020.010.01
Operating Cash Flow Ratio0.26-0.070.090.130.2
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 13 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Medico Remedies Ltd6.6137.70Overvalued17.001.5813.00
2Kilitch Drugs (India) Ltd6.6121.54Neutral37.009.2730.00
3Kopran Ltd6.6025.82Neutral62.006.3026.00
4SMS Lifesciences India Ltd6.5921.20Undervalued45.0070.6819.00
5Infinium Pharmachem Ltd6.4226.90Neutral22.006.4314.00
6Medicamen Biotech Ltd5.7332.19Neutral20.006.9410.00
7Aarey Drugs & Pharmaceuticals Ltd5.7359.71Neutral7.001.404.00
8Albert David Ltd5.63-272.47Neutral5.00-2.62-1.00
9BPL Ltd5.46-31.11Neutral-4.82-3.00-8.55
10Zim Laboratories Ltd5.4141.96Neutral30.001.116.00
11Lyka Labs Ltd4.77-23.98Neutral-4.00-9.05-10.00
12Nectar Lifescience Ltd3.83-2.67Neutral-59.00-2.95-293.00
Management Assessment Summary
OrangeBalanced Management

The management of SMS Lifesciences demonstrates a mixed performance. Revenue growth has been inconsistent, with a recent increase in sales offset by earlier declines. Profitability margins vary, and while there's been recent YOY profit growth, it follows a period of significant declines. Capital efficiency, as indicated by ROCE and ROE, is modest but has shown improvement. The company's debt management shows some control, but interest coverage could be better. Promoter holding is high, indicating confidence. Overall, SMS Lifesciences shows potential but needs consistent improvements in both sales and profitability.

Category Metric Value Assessment
PROS Promoter Holding 71.40% High promoter holding indicates strong management alignment
PROS Sales Growth 2025 12.67% Shows recovery in revenue generation
CONS Interest Coverage Ratio (2024) 3.1 Indicates potential challenges in meeting interest obligations
CONS ROCE (2024) 7% Suggests suboptimal capital allocation efficiency
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
AverageFinancial Health & PrudenceAverage
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for SMS Lifesciences indicates a moderate level of concern. The company's working capital management needs improvement, as indicated by the high cash conversion cycle. However, promoter holding is strong, indicating confidence. Overall, SMS Lifesciences faces risks related to operational efficiency and financial stability, but these are somewhat mitigated by strong promoter backing.

WeakWorking Capital ManagementWeak
01.

Working Capital Management

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101439.55Bearish
  3. SMA 201426.43Bearish
  4. SMA 501415.93Bearish
  5. EMA 101426.69Bearish
  6. EMA 201427.34Bearish
  7. EMA 501422.59Bearish
  8. DEMA 101419.19Bearish
  9. DEMA 201432.17Bearish
  10. DEMA 501418.47Bearish
  11. TEMA 101405.92Bearish
  12. TEMA 201428.56Bearish
  13. TEMA 501438.90Bearish
  14. MACD2.17Bearish
  15. ADX21.33Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI41.38Neutral
  3. CCI-75.68Neutral
  4. ROC 9-5.45Bearish
  5. ROC 14-1.04Bearish
  6. ROC 25-3.62Bearish
  7. Stoch K27.77Neutral
  8. Stoch D46.56Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1486.98Neutral
  3. BB Middle1426.43Neutral
  4. BB Lower1365.88Neutral
  5. ATR29.33High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI31.05Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101431.03Bearish
  3. SMA 201418.89Bearish
  4. SMA 501403.75Bearish
  5. EMA 101421.01Bearish
  6. EMA 201418.78Bearish
  7. EMA 501429.82Bearish
  8. DEMA 101419.75Bearish
  9. DEMA 201423.01Bearish
  10. DEMA 501396.05Bearish
  11. TEMA 101411.26Bearish
  12. TEMA 201429.89Bearish
  13. TEMA 501398.08Bearish
  14. MACD2.69Bearish
  15. ADX19.32Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI44.65Neutral
  3. CCI-77.55Neutral
  4. ROC 9-1.04Bearish
  5. ROC 14-2.62Bearish
  6. ROC 25-0.09Bearish
  7. Stoch K32.09Neutral
  8. Stoch D52.70Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1475.23Neutral
  3. BB Middle1418.90Neutral
  4. BB Lower1362.56Neutral
  5. ATR39.58High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI23.52Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101415.01Bearish
  3. SMA 201403.48Bearish
  4. SMA 501488.77Bearish
  5. EMA 101414.94Bearish
  6. EMA 201420.32Bearish
  7. EMA 501450.57Bearish
  8. DEMA 101417.24Bearish
  9. DEMA 201397.38Bearish
  10. DEMA 501439.28Bearish
  11. TEMA 101421.77Bearish
  12. TEMA 201411.71Bearish
  13. TEMA 50N/AN/A
  14. MACD-13.70Bullish
  15. ADX13.58Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI42.53Neutral
  3. CCI3.52Neutral
  4. ROC 9-1.77Bearish
  5. ROC 14-1.11Bearish
  6. ROC 25-4.08Bearish
  7. Stoch K58.01Neutral
  8. Stoch D69.45Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1454.86Neutral
  3. BB Middle1403.48Neutral
  4. BB Lower1352.10Neutral
  5. ATR54.41High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI30.38Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 101405.13Bullish
  3. SMA 201466.32Bearish
  4. SMA 501461.81Bearish
  5. SMA 1001359.62Bullish
  6. SMA 2001296.13Bullish
  7. EMA 101422.07Bearish
  8. EMA 201446.59Bearish
  9. EMA 501441.16Bearish
  10. EMA 1001391.67Bullish
  11. EMA 2001328.53Bullish
  12. DEMA 101400.22Bullish
  13. DEMA 201414.68Bearish
  14. DEMA 501490.20Bearish
  15. DEMA 1001476.27Bearish
  16. DEMA 2001428.53Bearish
  17. TEMA 101412.97Bearish
  18. TEMA 201377.03Bullish
  19. TEMA 501474.19Bearish
  20. TEMA 1001507.74Bearish
  21. TEMA 2001450.40Bearish
  22. MACD-25.77Bearish
  23. ADX17.07Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI45.17Neutral
  3. CCI-39.15Neutral
  4. ROC 14-0.92Bearish
  5. ROC 25-12.46Bearish
  6. Stoch K45.06Neutral
  7. Stoch D34.39Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1672.43Neutral
  3. BB Middle1466.33Neutral
  4. BB Lower1260.22Neutral
  5. ATR87.31High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI35.49Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 201366.40Bullish
  3. SMA 501273.06Bullish
  4. EMA 201398.19Bullish
  5. EMA 501309.13Bullish
  6. DEMA 201484.97Bearish
  7. DEMA 501421.39Bearish
  8. TEMA 201519.68Bearish
  9. TEMA 501433.22Bearish
  10. MACD67.29Bullish
  11. ADX24.74Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI53.03Neutral
  3. CCI79.42Neutral
  4. ROC 1411.34Bullish
  5. ROC 2515.24Bullish
  6. Stoch K46.58Neutral
  7. Stoch D59.43Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1640.04Neutral
  3. BB Middle1366.40Neutral
  4. BB Lower1092.76Neutral
  5. ATR150.96Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI68.64Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 61333.18Bullish
  3. SMA 121265.16Bullish
  4. SMA 241234.62Bullish
  5. EMA 61376.46Bullish
  6. EMA 121299.39Bullish
  7. EMA 241182.82Bullish
  8. DEMA 61469.41Bullish
  9. DEMA 121413.77Bullish
  10. DEMA 241390.87Bullish
  11. TEMA 61517.34Bullish
  12. TEMA 121428.58Bullish
  13. TEMA 241426.91Bullish
  14. MACD218.51Bullish
  15. ADX43.91Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI64.34Neutral
  3. CCI144.48Overbought
  4. ROC 25127.51Bullish
  5. ROC 50126.14Bullish
  6. Stoch K58.11Neutral
  7. Stoch D60.35Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1500.97Overbought
  3. BB Middle1248.82Neutral
  4. BB Lower996.68Neutral
  5. ATR249.30High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI49.96Neutral